journal article·2018-11-05Open access

Comparison of conventional and advancedin vitromodels in the toxicity testing of nanoparticles

Eleonore Fröhlich

Abstract

Humans are exposed to a wide variety of nanoparticles (NPs) present in the environment, in consumer, health and medical products, and in food. Conventional cytotoxicity testing compared to animal testing is less expensive, faster and avoids ethical problems at the expense of a lower predictive value. New cellular models and exposure conditions have been developed to overcome the limitations of conventional cell culture and obtain more predictive data. The use of three-dimensional culture, co-culture and inclusion of mechanical stimulation can provide physiologically more relevant culture conditions. These systems are particularly relevant for oral, respiratory and intravenous exposure to NPs and it may be assumed that physiologically relevant application of the NPs can improve the predictive value of in vitro testing. Various groups have used advanced culture and exposure systems, but few direct comparisons between data from conventional cultures and from advanced systems exist. In silico models may present another option to predict human health risk by NPs without using animal studies. In the absence of validation, the question whether these alternative models provide more predictive data than conventional testing remains elusive.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Nanoparticles: synthesis and applications · Animal testing and alternatives

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Medical Research, Medical University of Graz, Graz, Austria

Funding

Austrian Science Fund

References (100+)

Show source-provided references
1. 10.2174/13816120577441451010.2174/138161205774414510 ↗
2. European Commission. Ban on Animal Testing: European Commission; 2017 [cited 2017 August, 12]. Available from: https://ec.europa.eu/growth/sectors/cosmetics/animal-testing_de
3. 10.1016/0014-2999(70)90302-X10.1016/0014-2999(70)90302-X ↗
4. 10.1016/B978-0-444-53856-7.00004-X10.1016/B978-0-444-53856-7.00004-X ↗
5. 10.1016/j.tox.2009.05.01710.1016/j.tox.2009.05.017 ↗
6. 10.2147/IJN.S8306810.2147/IJN.S83068 ↗
7. 10.1016/j.memsci.2013.11.03410.1016/j.memsci.2013.11.034 ↗
8. 10.1016/j.toxlet.2005.07.00510.1016/j.toxlet.2005.07.005 ↗
9. 10.1016/j.toxrep.2014.03.00310.1016/j.toxrep.2014.03.003 ↗
10. 10.1016/j.jhazmat.2017.04.04110.1016/j.jhazmat.2017.04.041 ↗
11. 10.1038/micronano.2015.1510.1038/micronano.2015.15 ↗
12. 10.1039/c2lc40074j10.1039/c2lc40074j ↗
13. 10.1039/c3ib40126j10.1039/c3ib40126j ↗
14. 10.1371/journal.pone.006876110.1371/journal.pone.0068761 ↗
15. 10.1124/dmd.111.04246510.1124/dmd.111.042465 ↗
16. 10.2174/156802661466614032922534010.2174/1568026614666140329225340 ↗
17. 10.1016/j.ejpb.2012.10.00310.1016/j.ejpb.2012.10.003 ↗
18. 10.1038/nnano.2012.310.1038/nnano.2012.3 ↗
19. 10.1021/mp400507g10.1021/mp400507g ↗
20. 10.2217/rme.09.410.2217/rme.09.4 ↗
21. 10.1089/ten.tec.2012.046310.1089/ten.tec.2012.0463 ↗
22. 10.1371/journal.pone.008629710.1371/journal.pone.0086297 ↗
23. 10.1136/gut.47.1.7910.1136/gut.47.1.79 ↗
24. 10.1038/8637310.1038/86373 ↗
25. 10.1182/blood-2004-11-432110.1182/blood-2004-11-4321 ↗
26. 10.1039/C2LC40845G10.1039/C2LC40845G ↗
27. 10.1021/mp100079510.1021/mp1000795 ↗
28. 10.1016/j.jnutbio.2008.05.00610.1016/j.jnutbio.2008.05.006 ↗
29. 10.1016/j.tox.2013.06.00210.1016/j.tox.2013.06.002 ↗
30. 10.1039/C4LC00371C10.1039/C4LC00371C ↗
31. 10.1016/0146-6453(94)90004-310.1016/0146-6453(94)90004-3 ↗
32. 10.1515/entl-2015-000410.1515/entl-2015-0004 ↗
33. 10.1152/ajplung.00059.201110.1152/ajplung.00059.2011 ↗
34. 10.1186/1743-8977-8-3610.1186/1743-8977-8-36 ↗
35. Kuehn A · Altex · 2016 · 33 · 251
36. 10.1016/j.tox.2017.01.00110.1016/j.tox.2017.01.001 ↗
37. 10.1165/rcmb.2004-0187OC10.1165/rcmb.2004-0187OC ↗
38. 10.1186/1743-8977-10-1110.1186/1743-8977-10-11 ↗
39. 10.1183/09031936.0004400810.1183/09031936.00044008 ↗
40. 10.1186/1743-8977-10-3110.1186/1743-8977-10-31 ↗
41. 10.1007/s10544-009-9325-510.1007/s10544-009-9325-5 ↗
42. 10.1371/journal.pone.008830410.1371/journal.pone.0088304 ↗
43. 10.1023/A:101225952916710.1023/A:1012259529167 ↗
44. 10.1166/jnn.2009.GR0910.1166/jnn.2009.GR09 ↗
45. 10.3390/microarrays401006410.3390/microarrays4010064 ↗
46. 10.1088/1758-5082/5/4/04500810.1088/1758-5082/5/4/045008 ↗
47. 10.1016/j.addr.2017.07.00410.1016/j.addr.2017.07.004 ↗
48. 10.1016/j.biomaterials.2011.07.02810.1016/j.biomaterials.2011.07.028 ↗
49. 10.1007/978-1-4939-2074-7_510.1007/978-1-4939-2074-7_5 ↗
50. 10.1073/pnas.23213769910.1073/pnas.232137699 ↗
51. 10.1093/toxsci/kfs23210.1093/toxsci/kfs232 ↗
52. 10.1007/s00204-016-1677-z10.1007/s00204-016-1677-z ↗
53. 10.1016/j.taap.2009.11.00210.1016/j.taap.2009.11.002 ↗
54. 10.1124/dmd.110.03523810.1124/dmd.110.035238 ↗
55. 10.1038/srep2131610.1038/srep21316 ↗
56. 10.3109/17435390.2014.94809210.3109/17435390.2014.948092 ↗
57. 10.1080/10408444.2016.118104710.1080/10408444.2016.1181047 ↗
58. 10.1039/c3ib40049b10.1039/c3ib40049b ↗
59. 10.3109/17435390.2011.56232610.3109/17435390.2011.562326 ↗
60. 10.1007/s00432-016-2198-010.1007/s00432-016-2198-0 ↗
61. 10.4172/2155-9872.100024910.4172/2155-9872.1000249 ↗
62. 10.1021/nn203659m10.1021/nn203659m ↗
63. 10.1371/journal.pone.005679110.1371/journal.pone.0056791 ↗
64. 10.1021/ac301191j10.1021/ac301191j ↗
65. Lee J · Small · 2009 · 5 · 121310.1002/smll.200801788 ↗
66. 10.1016/j.jbiotec.2015.01.00110.1016/j.jbiotec.2015.01.001 ↗
67. 10.1186/s12989-016-0161-510.1186/s12989-016-0161-5 ↗
68. 10.1039/C6RA27334C10.1039/C6RA27334C ↗
69. 10.3390/ijms1305555410.3390/ijms13055554 ↗
70. 10.1007/s10439-005-9004-510.1007/s10439-005-9004-5 ↗
71. 10.1002/bit.2169810.1002/bit.21698 ↗
72. 10.1016/S0168-3659(00)00269-810.1016/S0168-3659(00)00269-8 ↗
73. 10.1016/j.ejpb.2010.05.00210.1016/j.ejpb.2010.05.002 ↗
74. Kim K · J Korean Soc Appl Biol Chem · 2011 · 54 · 30
75. 10.1186/1743-8977-8-610.1186/1743-8977-8-6 ↗
76. 10.1155/2013/80121410.1155/2013/801214 ↗
77. 10.1016/j.toxlet.2017.07.87710.1016/j.toxlet.2017.07.877 ↗
78. 10.1186/s12989-016-0117-910.1186/s12989-016-0117-9 ↗
79. 10.1186/s12989-014-0068-y10.1186/s12989-014-0068-y ↗
80. 10.1007/s13346-013-0129-z10.1007/s13346-013-0129-z ↗
81. 10.1016/j.ijpharm.2016.10.02010.1016/j.ijpharm.2016.10.020 ↗
82. 10.1016/j.ejps.2014.07.00310.1016/j.ejps.2014.07.003 ↗
83. 10.3109/17435390.2014.98866410.3109/17435390.2014.988664 ↗
84. 10.1089/jam.2006.19.39210.1089/jam.2006.19.392 ↗
85. 10.1016/j.tiv.2012.08.00810.1016/j.tiv.2012.08.008 ↗
86. 10.1021/acs.est.7b0049310.1021/acs.est.7b00493 ↗
87. 10.1371/journal.pone.013569010.1371/journal.pone.0135690 ↗
88. 10.5772/6070110.5772/60701 ↗
89. 10.3762/bjnano.5.14910.3762/bjnano.5.149 ↗
90. 10.1165/rcmb.2013-0479OC10.1165/rcmb.2013-0479OC ↗
91. 10.1186/1743-8977-6-3210.1186/1743-8977-6-32 ↗
92. 10.1088/0957-4484/22/11/11510110.1088/0957-4484/22/11/115101 ↗
93. 10.1201/b10780-1110.1201/b10780-11 ↗
94. 10.1016/j.jconrel.2015.08.00810.1016/j.jconrel.2015.08.008 ↗
95. 10.1016/j.mvr.2014.10.01010.1016/j.mvr.2014.10.010 ↗
96. Samuel SP · Int J Nanomedicine · 2012 · 7 · 2943
97. 10.3233/JCB-1502010.3233/JCB-15020 ↗
98. 10.2217/nnm.15.21610.2217/nnm.15.216 ↗
99. 10.1007/s10565-013-9265-y10.1007/s10565-013-9265-y ↗
100. 10.1016/j.colsurfb.2014.02.03510.1016/j.colsurfb.2014.02.035 ↗